Direkt zum Inhalt
Merck

GLYCOPRO

Sigma-Aldrich

Glycoprotein Detection Kit

Sufficient for 10 mini-gels (10 × 10 cm) or 5 gels or membranes (16.5 × 19 cm)

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352200
NACRES:
NA.32

Qualitätsniveau

Verwendung

 kit sufficient for 10 mini-gels (10 × 10 cm)
 kit sufficient for 5 gels or membranes (16.5 × 19 cm)

carbohydrate detection limit measuring range

25-100 ng/band

Lagertemp.

2-8°C

Anwendung

The Glycoprotein Detection Kit is designed for the selective staining of glycoproteins on polyacrylamide gels and membranes using a modification of the Periodic Acid-Schiff (PAS) method. Staining of sugar moieties of glycoproteins yields magenta bands with a colorless background. The periodic acid/Schiff reagent stains vicinal diol groups found mainly on peripheral sugars and sialic acids and is used as a general glycoprotein stain.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1B - Eye Dam. 1 - Met. Corr. 1 - Ox. Liq. 1 - Resp. Sens. 1 - Skin Corr. 1A - STOT RE 1 Oral - STOT SE 1

Zielorgane

Eyes,Central nervous system, Thyroid

Zusätzliche Gefahrenhinweise

Lagerklassenschlüssel

5.1A - Strongly oxidizing hazardous materials

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Silvia Gómez-Sebastián et al.
BMC biotechnology, 12, 59-59 (2012-09-08)
Single-domain antibodies (sdAbs), also known as nanobodies or VHHs, are characterized by high stability and solubility, thus maintaining the affinity and therapeutic value provided by conventional antibodies. Given these properties, VHHs offer a novel alternative to classical antibody approaches. To
Feng Wang-Johanning et al.
Journal of the National Cancer Institute, 104(3), 189-210 (2012-01-17)
The envelope (env) protein of the human endogenous retrovirus type K (HERV-K) family is commonly expressed on the surface of breast cancer cells. We assessed whether HERV-K env is a potential target for antibody-based immunotherapy of breast cancer. We examined
Sukanya Narasimhan et al.
Nature communications, 8(1), 184-184 (2017-08-05)
The Lyme disease agent, Borrelia burgdorferi, colonizes the gut of the tick Ixodes scapularis, which transmits the pathogen to vertebrate hosts including humans. Here we show that B. burgdorferi colonization increases the expression of several tick gut genes including pixr
Electrophoresis: Theory, Techniques, and Biochemical and Clinical Applications.
Andrews, A.T., ed.
Biochemical and Clinical Applications, 2nd ed, 38-42 (1988)
Anthony G Tsolaki et al.
Molecular immunology, 54(3-4), 278-283 (2013-01-22)
In this study, we investigated the potential molecular and immunological differences of a recombinant fusion protein (Hybrid-1), comprising of the immunodominant antigens Ag85B and ESAT-6 from Mycobacterium tuberculosis, derived from two different expression systems, namely Mycobacterium smegmatis and Escherichia coli.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.